Intravitreal Injection Versus Sub-Tenon’s Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema: A Randomized Clinical Trial-Reference-Cited by-同舟云学术

Intravitreal Injection Versus Sub-Tenon’s Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema: A Randomized Clinical Trial

Published:2005-10-01 Issue:10 Volume:46 Page:3845
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Bonini-Filho Marco A.¹,Jorge Rodrigo¹,Barbosa Jose´ C.²,Calucci Daniela³,Cardillo Jose A.³,Costa Roge´rio A.⁴

Affiliation:

1. From the Department of Ophthalmology, School of Medicine of Ribeira~o Preto, Ribeira~o Preto-SP, Brazil; the

2. Exact Sciences Department, Universidade Estadual Paulista, Jaboticabal-SP, Brazil; and

3. Retina Diagnostic and Treatment Division, Hospital de Olhos de Araraquara, Araraquara-SP, Brazil.

4. From the Department of Ophthalmology, School of Medicine of Ribeira~o Preto, Ribeira~o Preto-SP, Brazil; the3Retina Diagnostic and Treatment Division, Hospital de Olhos de Araraquara, Araraquara-SP, Brazil.

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of intravitreal preservative-free triamcinolone versus posterior sub-tenon triamcinolone acetonide injection for bevacizumab-resistant diabetic macular edema;BMC Ophthalmology;2024-01-19

2. Combined Treatment of Persistent Diabetic Macular Edema with Aflibercept and Triamcinolone Acetonide in Pseudophakic Eyes;Medicina;2023-05-19

3. Combined intravitreal dexamethasone and bevacizumab injection for the treatment of persistent diabetic macular edema (DexaBe study): a phase I clinical study;International Journal of Retina and Vitreous;2023-03-03

4. Subtenon triamcinolone as an adjuvant in mitomycin-C-enhanced trabeculectomy in non-inflammatory glaucomas: A randomized clinical trial;PLOS ONE;2022-05-26

5. Recent trends in drug-delivery systems for the treatment of diabetic retinopathy and associated fibrosis;Advanced Drug Delivery Reviews;2021-06